INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
申请人:BLUEPRINT MEDICINES CORPORATION
公开号:US20170066812A1
公开(公告)日:2017-03-09
Described herein are inhibitors of FGFR, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of tyrosine kinases.